Provides for review of fees charged for external review
Impact
The legislative intent behind HB 188 is to protect consumers by enhancing the external review process, making it more equitable and accessible. By placing the financial responsibility for the review on the issuers, the bill aims to discourage arbitrary denials from insurers and promote a fair assessment of claims. This change is expected to minimize the out-of-pocket costs for patients while encouraging insurance companies to maintain justified coverage policies.
Summary
House Bill 188 focuses on the funding of external reviews requested by health insurance issuers in Louisiana. The bill mandates that health insurance issuers cover the costs associated with independent external reviews, which are meant to evaluate the necessity and appropriateness of coverage denials or disputes. Importantly, it specifies that no charges may be passed on to the patients involved in these reviews. This regulation aims to ensure that covered persons do not bear additional financial burdens when seeking external evaluations of their claims.
Sentiment
The sentiment towards HB 188 has been predominantly positive among consumer advocacy groups and supporters within the legislative body who view it as a necessary step toward more transparent and fair insurance practices. They argue that the bill strengthens consumer rights and facilitates better access to necessary medical care without the fear of incurring additional legal costs. However, there have been concerns from some insurance groups regarding the potential financial implications this could have on their operations, albeit these concerns did not prevent the bipartisan support the bill received.
Contention
While HB 188 passed without opposition, the discussions highlighted some lingering considerations related to the reasonableness of the review costs and the criteria by which they are determined. The bill includes provisions for insurers who contest the fees charged by independent review organizations to appeal to the insurance commissioner. This appeal process aims to establish reasonable standards for review costs, a point that could invoke further scrutiny in future legislative contexts.
Relates to the use of artificial intelligence by insurers and clinical peer reviewers for utilization review; establishes additional notice requirements for adverse determinations.
Relates to the use of artificial intelligence by insurers and clinical peer reviewers for utilization review; establishes additional notice requirements for adverse determinations.